IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

New Leaf Venture Partners, L.L.C.

Q4 2015 Holdings

Filed 2016-02-16 | 10 holdings | $149.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Edge Therapeutics IncCOM279870109$29.3K2,344,86819.6%
Versartis IncCOM92529L102$25.3K2,039,22316.9%
Dimension Therapeutics IncCOM25433V105$23.2K2,059,28315.6%
Alder Biopharmaceuticals IncCOM14339105$16.5K500,39811.1%
Oxford Immunotec Global PLCORD SHSG6855A103$15.8K1,377,49710.6%
Dynavax Technologies Corp(DVAX)COM NEW268158201$13.2K546,9988.8%
Wave Life Sciences PTE LTD(WVE)SHSY95308105$12.5K784,1598.4%
Dermira Inc(DERMEUR)COM24983L104$6.1K177,0224.1%
Marinus Pharmaceuticals IncCOM56854Q101$5.4K704,5723.6%
Chimerix Inc(CMRXEUR)COM16934W106$2.0K220,5331.3%